.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Clinicians are increasingly encountering patients particularly influenced by online trends regarding weight loss medications. A recent cross-sectional study investigated the semaglutide social media information available on popular platforms like TikTok and Bilibili. This research highlights an unchecked information environment that may lead to unsupervised use and a misunderstanding of clinical risks.
Researchers analyzed the top 100 videos from each platform using validated tools including the JAMA benchmark criteria and the DISCERN tool. Interestingly, the study found no statistically significant differences in quality scores between TikTok and Bilibili. However, the overall reliability remains a concern because many videos emphasize personal experience over evidence-based medical guidance.
The analysis further revealed that videos specifically produced by non-professional organizations achieved higher JAMA scores compared to individual creators. Consequently, while organizations provide more structured data, individual influencers often dominate engagement metrics despite lower reliability. Therefore, patients might prioritize relatable stories over safety profiles. In addition, within the Indian healthcare context, where generic semaglutide is gaining traction, these findings clearly underscore the need for clinician-led education.
No, most videos on TikTok and Bilibili exhibit suboptimal quality. While professional organizations provide better data, individual experiences often lack the clinical nuance required for safe treatment.
The primary risks primarily include self-medication, incorrect dosing, and a failure to understand serious side effects such as pancreatitis or gallbladder issues.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare consultation. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Zeng J et al. Quality and Reliability of Semaglutide-Related Short Videos on TikTok and Bilibili. Am J Health Promot. 2026 May 04. doi: 10.1177/08901171261447644. PMID: 42077173.
Song J et al. Quality and reliability of semaglutide content on different Chinese short video platforms. Front Public Health. 2026 Feb 24. doi: 10.3389/fpubh.2026.1750738.
Heiss R et al. Prescription Drug Content On Social Media Often Misleading. JAMA Network Open. 2026 Apr 11.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A cross-sectional study of 200 semaglutide videos on TikTok and Bilibili reveals suboptimal reliability and the risks of social media-driven self-medication...
5 months ago
Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today
A cross-sectional study reveals that maternal RSV vaccination coverage reached only 43.7% in Argentina, with maternal vaccine knowledge being the sole independent predictor of uptake. Clinicians play a crucial role in eliminating informational and structural barriers to optimize infant health.
Today
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday
